ERBB2 and cancer: Here, we report that patients with triple-negative breast cancers (TNBCs) exhibited the lowest number of extracellular vesicles in the sera, whilst the highest was detected in ER+HER2+ cancers, reflected also in the higher level of CD63+ vesicles found within the ER+HER2+ local tumour microenvironment.